Skip to content

Drug interactions

Encainide + Paroxetine

Severity: Major

Encainide and Paroxetine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Encainide is metabolized by CYP2D6 to active metabolites, and paroxetine inhibits this enzyme. This shifts the balance of parent drug and metabolites and can change antiarrhythmic effect and proarrhythmic risk, as seen in poor metabolizers.

What this interaction means in plain words

Encainide and Paroxetine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Inhibition of CYP2D6-mediated metabolism of encainide to its active metabolites.

What to do

Avoid the combination if possible or monitor ECG (QRS and PR intervals) closely and adjust encainide dose. Consider an antidepressant that does not inhibit CYP2D6.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Encainide and Paroxetine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Encainide with Paroxetine?

MediHelp rates the interaction as major. Encainide and Paroxetine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Encainide is metabolized by CYP2D6 to active metabolites, and paroxetine inhibits this enzyme. This shifts the balance of parent drug and metabolites and can change antiarrhythmic effect and proarrhythmic risk, as seen in poor metabolizers.

How serious is the interaction between Encainide and Paroxetine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible or monitor ECG (QRS and PR intervals) closely and adjust encainide dose. Consider an antidepressant that does not inhibit CYP2D6.

What other medicines interact with Paroxetine?

MediHelp also lists interactions of Paroxetine with, for example, Isocarboxazid, Methylene blue, Phenelzine. The full list is on the Paroxetine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in